CPIG
NAGE

Chicago Partners Investment Group’s Niagen Bioscience NAGE Stock Holding History

Chicago Partners Investment Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
74,541
+26,035
+54% +$106K ﹤0.01% 1356
2026
Q1 		$244K Buy
+48,506
New +$262K 0.01% 1241
2019
Q3 		– Sell
-15,000
Closed -$67K – 340
2019
Q2 		$67K Hold
15,000
– – 0.01% 316
2019
Q1 		$62K Hold
15,000
– – 0.01% 308
2018
Q4 		$52K Hold
15,000
– – 0.01% 312
2018
Q3 		$52K Hold
15,000
– – 0.01% 512
2018
Q2 		$56K Hold
15,000
– – 0.01% 467
2018
Q1 		$63K Hold
15,000
– – 0.01% 418
2017
Q4 		$88K Buy
+15,000
New +$81K 0.01% 372

Other funds holding NAGE

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $121M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Chicago Partners Investment Group's NAGE Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Niagen Bioscience (NAGE) stake by 54% in Q2 2026, buying an estimated $106K and bringing the position to 74,541 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

Chicago Partners Investment Group first reported a position in NAGE in Q4 2017 and has held it in 9 quarters since. The position peaked at $244K in Q1 2026. 24 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Chicago Partners Investment Group held 74,541 shares of Niagen Bioscience worth $238K as of Q2 2026.
  • Chicago Partners Investment Group bought 26,035 Niagen Bioscience shares in Q2 2026, an estimated $106K.
  • Niagen Bioscience made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1356 holding.
  • Chicago Partners Investment Group first reported a position in Niagen Bioscience in Q4 2017 and has held it in 9 quarters since.
  • Chicago Partners Investment Group's Niagen Bioscience position peaked at $244K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.